X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-20 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale | $237.28 | -15,000 | 857,582 | -2% | -$3,559,176 | ||||||
| M | 2024-11-20 | TLSI | Trisalus Life Sciences, Inc. | Wahlstrom Mats | Dir, 10% | P - Purchase | $4.39 | +10,727 | 2,635,014 | 0% | +$47,057 | |||||
2024-11-21 | BSX | Boston Scientific Corp | Ludwig Edward J | Dir | S - Sale | $91.63 | -4,877 | 39,398 | -11% | -$446,902 | ||||||
2024-11-20 | NARI | Inari Medical, Inc. | Hykes Andrew | Pres, CEO | S - Sale | $50.83 | -3,000 | 447,960 | -1% | -$152,490 | ||||||
| D | 2024-11-20 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | P - Purchase | $2.75 | +1,818 | 147,553 | +1% | +$5,000 | |||||
| D | 2024-11-20 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | P - Purchase | $2.75 | +3,636 | 333,196 | +1% | +$9,999 | |||||
| D | 2024-11-20 | NXGL | Nexgel, Inc. | Zeldis Jerome B | Dir | P - Purchase | $2.75 | +3,636 | 106,664 | +4% | +$9,999 | |||||
| D | 2024-11-20 | NXGL | Nexgel, Inc. | Drapczuk Adam E III | CFO | P - Purchase | $2.75 | +17,500 | 99,994 | +21% | +$48,125 | |||||
| D | 2024-11-20 | NXGL | Nexgel, Inc. | Glassman Steven Mark | Dir | P - Purchase | $2.75 | +9,090 | 154,155 | +6% | +$24,998 | |||||
| D | 2024-11-20 | NXGL | Nexgel, Inc. | Stein John Nachum | Dir | P - Purchase | $2.75 | +3,636 | 471,456 | +1% | +$9,999 | |||||
| M | 2024-11-20 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $10.06 | -100,000 | 5,769,302 | -2% | -$1,006,000 | |||||
| M | 2024-11-20 | FNA | Paragon 28, Inc. | Mvm Partners, LLC | 10% | S - Sale | $10.33 | -254,947 | 10,631,198 | -2% | -$2,634,813 | |||||
2024-11-20 | LMAT | Lemaitre Vascular Inc | Jasinski Lawrence J | Dir | S - Sale | $103.50 | -198 | 5,111 | -4% | -$20,493 | ||||||
2024-11-20 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $74.73 | -4,259 | 71,192 | -6% | -$318,275 | ||||||
| M | 2024-11-20 | TNDM | Tandem Diabetes Care Inc | Blickenstaff Kim D | Dir | S - Sale | $31.04 | -40,000 | 165,190 | -19% | -$1,241,400 | |||||
2024-11-20 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale | $92.57 | -26,420 | 205,605 | -11% | -$2,445,724 | ||||||
2024-11-19 | SGHT | Sight Sciences, Inc. | Raheja Manohar K. | EVP, Research, Development | P - Purchase | $3.70 | +2,000 | 98,000 | +2% | +$7,400 | ||||||
2024-11-21 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | Dir, 10% | S - Sale | $3.73 | -551,802 | 5,603,436 | -9% | -$2,058,221 | ||||||
2024-11-21 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | Dir, 10% | P - Purchase | $3.73 | +551,802 | 5,603,436 | +11% | +$2,058,221 | ||||||
| D | 2024-11-19 | CVRX | Cvrx, Inc. | Verrastro Paul | CHIEF MKTG, STRAT OFFICER | S - Sale+OE | $13.58 | -1,430 | 835 | -63% | -$19,417 | |||||
2024-11-20 | SKIN | Beauty Health Co | Gruber Desiree | Dir | S - Sale | $1.50 | -14,663 | 119,514 | -11% | -$22,022 | ||||||
2024-11-20 | MMM | 3M Co | Reinseth Theresa E | SVP, CAO | S - Sale | $127.71 | -1,033 | 4,943 | -17% | -$131,925 | ||||||
2024-11-18 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $51.16 | -60,000 | 501,233 | -11% | -$3,069,521 | ||||||
2024-11-18 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $12.43 | -1,609 | 126,761 | -1% | -$20,001 | ||||||
| M | 2024-11-18 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $12.45 | -6,007 | 226,484 | -3% | -$74,803 | |||||
2024-11-18 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $12.68 | -2,439 | 194,623 | -1% | -$30,937 | ||||||
2024-11-18 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $12.58 | -10,048 | 649,826 | -2% | -$126,354 | ||||||
2024-11-18 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $239.74 | -600 | 64,044 | -1% | -$143,843 | ||||||
| D | 2024-11-15 | LMAT | Lemaitre Vascular Inc | Ross Bridget A | Dir | S - Sale+OE | $101.47 | -3,750 | 2,278 | -62% | -$380,513 | |||||
2024-11-15 | TNDM | Tandem Diabetes Care Inc | Novara Mark David | EVP, CHIEF COMMERCIAL OFFICER | P - Purchase | $23.24 | +532 | 532 | New | +$12,364 | ||||||
| D | 2024-11-18 | ICU | Seastar Medical Holding Corp | Chung Kevin | Chief Medical Officer | P - Purchase | $1.99 | +4,250 | 13,685 | +45% | +$8,458 | |||||
2024-11-15 | SYK | Stryker Corp | Stiles Spencer S | Group Pres | S - Sale | $391.16 | -514 | 52,244 | -1% | -$201,056 | ||||||
2024-11-15 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP, Chief Financal Officer | S - Sale | $75.51 | -3,500 | 80,774 | -4% | -$264,285 | ||||||
| D | 2024-11-15 | MMSI | Merit Medical Systems Inc | Millner F. Ann | Dir | S - Sale+OE | $101.55 | -12,500 | 32,391 | -28% | -$1,269,375 | |||||
| D | 2024-11-13 | LMAT | Lemaitre Vascular Inc | Shadan Martha | Dir | S - Sale+OE | $103.38 | -1,466 | 1,304 | -53% | -$151,547 | |||||
2024-11-13 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale | $94.08 | -26,420 | 232,025 | -10% | -$2,485,573 | ||||||
2024-11-13 | FNA | Paragon 28, Inc. | Wright Kristina | Dir | S - Sale | $10.00 | -4,181 | 34,478 | -11% | -$41,810 | ||||||
2024-11-12 | UFPT | Ufp Technologies Inc | Holt Jason | VP | S - Sale | $342.69 | -146 | 6,721 | -2% | -$50,033 | ||||||
2024-11-12 | DRIO | Dariohealth Corp. | Nelson Steven Charles | Chief Commercial Officer | P - Purchase | $0.91 | +5,000 | 55,000 | +10% | +$4,546 | ||||||
| M | 2024-11-12 | UFPT | Ufp Technologies Inc | Bailly R Jeffrey | CEO | S - Sale | $346.34 | -15,021 | 28,706 | -34% | -$5,202,302 | |||||
2024-11-13 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.70 | +7,736 | 15,675,964 | 0% | +$5,423 | ||||||
2024-11-12 | RMD | Resmed Inc | De Witte Jan | Dir | S - Sale | $248.81 | -796 | 6,723 | -11% | -$198,053 | ||||||
| D | 2024-11-11 | GUTS | Fractyl Health, Inc. | Rajagopalan Harith | CEO | S - Sale+OE | $2.47 | -96,517 | 1,094,309 | -8% | -$238,358 | |||||
| D | 2024-11-11 | GUTS | Fractyl Health, Inc. | Caplan Jay David | Pres, Chief Product Officer | S - Sale+OE | $2.47 | -64,197 | 631,160 | -9% | -$158,541 | |||||
2024-11-12 | PODD | Insulet Corp | Borio Luciana | Dir | S - Sale | $274.80 | -508 | 2,790 | -15% | -$139,598 | ||||||
2024-11-12 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.71 | +11,477 | 15,668,228 | 0% | +$8,151 | ||||||
| D | 2024-11-08 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale+OE | $87.66 | -30,580 | 39,706 | -44% | -$2,680,572 | |||||
| D | 2024-11-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $246.26 | -14,683 | 459,562 | -3% | -$3,615,821 | |||||
| D | 2024-11-11 | UFPT | Ufp Technologies Inc | Hudson Symeria | Dir | S - Sale+OE | $340.83 | -2,293 | 528 | -81% | -$781,519 | |||||
| M | 2024-11-08 | UFPT | Ufp Technologies Inc | Bailly R Jeffrey | CEO | S - Sale | $348.40 | -25,416 | 43,727 | -37% | -$8,854,990 | |||||
2024-11-08 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $249.00 | -1,000 | 94,864 | -1% | -$249,000 | ||||||
2024-11-11 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.71 | +9,658 | 15,656,751 | 0% | +$6,876 | ||||||
| D | 2024-11-07 | MMSI | Merit Medical Systems Inc | Parra Raul Jr. | CFO, Treasurer | S - Sale+OE | $102.18 | -5,361 | 19,131 | -22% | -$547,787 | |||||
| D | 2024-11-06 | GMED | Globus Medical Inc | Scavilla Daniel T | Pres, CEO | S - Sale+OE | $80.02 | -60,000 | 0 | -100% | -$4,801,200 | |||||
| D | 2024-11-06 | GMED | Globus Medical Inc | Huller Kelly | SVP, GC, Corporate Secretary | S - Sale+OE | $81.01 | -5,000 | 0 | -100% | -$405,050 | |||||
| D | 2024-11-07 | SYK | Stryker Corp | Lobo Kevin | Chair, CEO | S - Sale+OE | $368.70 | -57,313 | 100,722 | -36% | -$21,131,479 | |||||
2024-11-07 | PDEX | Pro Dex Inc | Charlton Alisha | CFO | S - Sale | $40.02 | -1,000 | 15,339 | -6% | -$40,020 | ||||||
2024-11-08 | UFPT | Ufp Technologies Inc | Feldmann Cynthia L | Dir | S - Sale | $352.30 | -647 | 4,049 | -14% | -$227,938 | ||||||
2024-11-06 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $248.74 | -2,000 | 83,204 | -2% | -$497,480 | ||||||
| M | 2024-11-05 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | S - Sale | $96.33 | -100,000 | 171,228 | -37% | -$9,633,438 | |||||
| D | 2024-11-05 | MMSI | Merit Medical Systems Inc | Peterson Neil | COO | S - Sale+OE | $98.00 | -5,000 | 14,819 | -25% | -$490,000 | |||||
| D | 2024-11-05 | MMSI | Merit Medical Systems Inc | Parra Raul Jr. | CFO, Treasurer | S - Sale+OE | $98.02 | -29,646 | 19,131 | -61% | -$2,905,901 | |||||
| D | 2024-11-05 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $84.75 | -162,778 | 1,730,483 | -9% | -$13,794,851 | |||||
2024-11-05 | SYK | Stryker Corp | Stryker Ronda E | Dir, 10% | S - Sale | $367.37 | -230,000 | 18,179,063 | -1% | -$84,494,990 | ||||||
2024-11-04 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $13.55 | -341 | 128,370 | 0% | -$4,621 | ||||||
| D | 2024-11-02 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale+OE | $16.69 | -44 | 33,597 | 0% | -$734 | |||||
2024-11-06 | IRMD | Iradimed Corp | Vuoto Anthony | Dir | S - Sale | $55.99 | -2,690 | 14,234 | -16% | -$150,616 | ||||||
| D | 2024-11-01 | INSP | Inspire Medical Systems, Inc. | Rondoni John | CTO | S - Sale+OE | $193.47 | -8,703 | 11,348 | -43% | -$1,683,731 | |||||
2024-11-01 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $242.00 | -69 | 10,443 | -1% | -$16,698 | ||||||
2024-11-04 | IRTC | Irhythm Technologies, Inc. | Talwalkar Abhijit Y | Dir | P - Purchase | $75.16 | +6,664 | 18,941 | +54% | +$500,866 | ||||||
2024-11-04 | IRTC | Irhythm Technologies, Inc. | Blackford Quentin S. | Pres, CEO | S - Sale | $77.41 | -16,145 | 159,929 | -9% | -$1,249,784 | ||||||
| D | 2024-11-01 | ICUI | Icu Medical Inc/de | Jain Vivek | COB, CEO | S - Sale+OE | $171.85 | -12,000 | 193,291 | -6% | -$2,062,136 | |||||
2024-10-31 | NVCR | Novocure Ltd | Puri Michal Nath | CHRO | S - Sale | $15.79 | -810 | 110,093 | -1% | -$12,792 | ||||||
2024-11-01 | NVCR | Novocure Ltd | Leonard Frank X | EVP, Pres, Novocure Oncology | S - Sale | $15.94 | -598 | 161,236 | 0% | -$9,531 | ||||||
2024-11-01 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale | $15.88 | -160 | 3,503 | -4% | -$2,540 | ||||||
| D | 2024-11-01 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $84.33 | -6,983 | 32,028 | -18% | -$588,876 | |||||
2024-11-01 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.71 | +8,657 | 15,647,093 | 0% | +$6,128 | ||||||
2024-10-31 | SSII | Ss Innovations International, Inc. | Adams Timothy P. | Dir | P - Purchase | $1.46 | +1,399,595 | 2,381,282 | +143% | +$2,043,409 | ||||||
2024-10-31 | SSII | Ss Innovations International, Inc. | Srivastava Sudhir | COB, CEO, 10% | S - Sale | $1.46 | -1,399,595 | 115,542,523 | -1% | -$2,043,409 | ||||||
| M | 2024-10-30 | SNWVD | Sanuwave Health, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $15.75 | +27,868 | 972,002 | +3% | +$438,902 | |||||
| D | 2024-10-30 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $138.97 | -2,275 | 102,169 | -2% | -$316,157 | |||||
2024-10-30 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.71 | +601 | 15,638,436 | 0% | +$429 | ||||||
2024-10-29 | NARI | Inari Medical, Inc. | Hykes Andrew | Pres, CEO | S - Sale | $50.00 | -3,000 | 450,960 | -1% | -$150,000 | ||||||
2024-10-29 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $50.05 | -40,000 | 561,233 | -7% | -$2,002,000 | ||||||
| D | 2024-10-30 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale+OE | $91.00 | -288,461 | 258,445 | -53% | -$26,249,951 | |||||
| D | 2024-10-29 | WST | West Pharmaceutical Services Inc | Witherspoon Charles | VP, Treasurer | S - Sale+OE | $310.40 | -703 | 1,253 | -36% | -$218,211 | |||||
2024-10-28 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.14 | +50,000 | 10,435,090 | 0% | +$7,080 | ||||||
| M | 2024-10-23 | NPCE | Neuropace Inc | Kck Ltd. | 10% | S - Sale | $5.45 | -224,138 | 5,270,845 | -4% | -$1,221,927 | |||||
2024-10-24 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.72 | +11,441 | 15,637,835 | 0% | +$8,180 | ||||||
2024-10-24 | TELA | Tela Bio, Inc. | Cuca Roberto | COO, CFO | P - Purchase | $2.25 | +64,444 | 155,388 | +71% | +$144,999 | ||||||
2024-10-24 | TELA | Tela Bio, Inc. | Talmo Paul | CTO | P - Purchase | $2.25 | +22,222 | 91,082 | +32% | +$50,000 | ||||||
2024-10-24 | TELA | Tela Bio, Inc. | Koblish Antony | CEO | P - Purchase | $2.25 | +88,888 | 458,897 | +24% | +$199,998 | ||||||
2024-10-24 | TELA | Tela Bio, Inc. | Firestone Gregory A. | Chief Commercial Officer | P - Purchase | $2.25 | +6,666 | 57,279 | +13% | +$14,999 | ||||||
2024-10-22 | NPCE | Neuropace Inc | Kck Ltd. | 10% | S - Sale | $6.09 | -4,082 | 5,494,983 | 0% | -$24,853 | ||||||
2024-10-23 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.74 | +21,142 | 15,626,394 | 0% | +$15,662 | ||||||
2024-10-21 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale | $204.56 | -15,000 | 872,582 | -2% | -$3,068,367 | ||||||
| D | 2024-10-18 | SNWV | Sanuwave Health, Inc. | Manchester Management Co LLC | Director by Deputization | P - Purchase | $8.25 | +181,818 | 140,652 | -442% | +$1,499,999 | |||||
| M | 2024-10-18 | NPCE | Neuropace Inc | Kck Ltd. | 10% | S - Sale | $6.21 | -8,598 | 5,499,065 | 0% | -$53,370 | |||||
| M | 2024-10-18 | SGHT | Sight Sciences, Inc. | Link Matthew | Chief Commercial Officer | S - Sale | $5.79 | -42,318 | 663,550 | -6% | -$244,901 | |||||
2024-10-17 | LUNG | Pulmonx Corp | French Glendon E. III | Dir | S - Sale | $6.52 | -20,000 | 1,091,974 | -2% | -$130,400 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |